# 매칭되지 않은 약어 리포트

생성일시: 2025-12-22 11:49:07

## Top 50 매칭되지 않은 약어

| 약어 | 검출 횟수 | Study 수 | Primary | Secondary | 샘플 Measure |
|------|----------|---------|---------|----------|-------------|
| (CogState) | 17 | 3 | 2 | 15 | Change From Baseline (Day 0) in the Computerize... |
| (CGI-S) | 15 | 15 | 1 | 14 | Change From Baseline in Clinical Global Impress... |
| (CGI-I) | 13 | 10 | 1 | 12 | Change from baseline in Clinical Global Impress... |
| (SIB) | 10 | 9 | 5 | 5 | Change From Baseline in Severe Impairment Batte... |
| (Safety assessments) | 10 | 1 | 0 | 10 | Alkaline phosphatase (Safety assessments) | Cal... |
| (Safety Assessment) | 9 | 1 | 0 | 9 | Calcium (Safety Assessment) | Creatinine (Safet... |
| (BARS) | 8 | 8 | 2 | 6 | Barnes Akathisia Rating Scale (BARS) | Barnes A... |
| (ADA) | 8 | 8 | 2 | 6 | DBT Period: Number of Participants With Anti-Dr... |
| (POMS) | 8 | 3 | 1 | 7 | Behavioral & Mood Measure: Profile of Mood Stat... |
| (AIMS) | 8 | 7 | 1 | 7 | Abnormal Involuntary Movement Scale (AIMS) | Ab... |
| (MOS-SS) | 8 | 1 | 8 | 0 | Medical Outcomes Study - Sleep Scale (MOS-SS) S... |
| (AD) | 7 | 7 | 5 | 2 | Biomarker NAA/mI Measured in Three Groups: Alzh... |
| (BMI) | 6 | 6 | 0 | 6 | Body Mass Index (BMI) | Change From Baseline in... |
| (NIS-LL) | 6 | 2 | 3 | 3 | Change From Baseline in Neuropathy Impairment S... |
| (MTD) | 6 | 5 | 4 | 2 | Donepezil Maximum Tolerated Dose (MTD) | Donepe... |
| (B) | 6 | 2 | 5 | 1 | Incidence of treatment-emergent changes in clin... |
| (cohorts A-C + D) | 5 | 1 | 5 | 0 | Incidence of treatment-emergent changes in clin... |
| (CGI) | 5 | 4 | 1 | 4 | Change From Baseline in Clinical Global Impress... |
| (ARCI) | 5 | 2 | 5 | 0 | Addiction Research Centre Inventory (ARCI) | Ne... |
| (cohort E) | 5 | 1 | 5 | 0 | Incidence of treatment-emergent changes in clin... |
| (HAMA) | 5 | 2 | 4 | 1 | Hamilton Anxiety Scale (HAMA) |
| (IPSS) | 4 | 4 | 0 | 4 | Change From Baseline in International Prostate ... |
| (Part B) | 4 | 2 | 4 | 0 | Percent Intact Tracer of 11C-JNJ-63779586 in Bl... |
| (CL) | 4 | 4 | 1 | 3 | Clearance (CL) after a single IV infusion of ad... |
| (Tlast) | 4 | 4 | 4 | 0 | Time to Last Quantifiable Plasma Concentration ... |
| (SAS) | 4 | 3 | 1 | 3 | Change from Baseline in Simpson-Angus Scale (SA... |
| (C24) | 4 | 4 | 1 | 3 | Concentration of HTL0009936 at 24 hours post do... |
| (GMLT) | 4 | 3 | 4 | 0 | Groton Maze Learning Test (GMLT) | Groton Maze ... |
| (MACE) | 4 | 2 | 0 | 4 | Extension Phase: Time to first occurrence of ma... |
| (Emin) | 4 | 1 | 4 | 0 | Balance of Effects- Drug Liking VAS: Peak Effec... |
| (CV) | 3 | 1 | 0 | 3 | Cardiovascular (CV) Hospitalization | Cardiovas... |
| (PSMS) | 3 | 3 | 0 | 3 | 4. Physical Self-Maintenance Scale (PSMS) | Phy... |
| (CGIS) | 3 | 3 | 0 | 3 | Change From Baseline in the Clinical Global Imp... |
| (SRT) | 3 | 3 | 2 | 1 | Change From Baseline in Buschke Selective Remin... |
| (nmol/L) | 3 | 1 | 0 | 3 | Mean and Median Thiamine Diphosphate (ThDP) lev... |
| (Assessed Semi-Annually) | 3 | 1 | 0 | 3 | Change from Baseline Over Time (Assessed Semi-A... |
| (neurodegeneration biomarker amyloid) | 3 | 3 | 0 | 3 | Change in blood inflammatory and neurodegenerat... |
| (Delayed Paragraph Recall) | 3 | 1 | 3 | 0 | Logical Memory II subscale (Delayed Paragraph R... |
| (version 2) | 3 | 1 | 3 | 0 | 12-month evaluations of associative, verbal mem... |
| (CBB) | 3 | 3 | 0 | 3 | Change from Baseline in Cogstate Brief Battery ... |
| (Severe Impairment Battery) | 3 | 2 | 2 | 1 | Change from baseline in SIB(Severe Impairment B... |
| (TEAE) | 3 | 3 | 1 | 2 | Number of Participants With at Least One Treatm... |
| (VRM) | 3 | 1 | 2 | 1 | Change From Baseline in the Verbal Recall Memor... |
| (S-STS) | 3 | 2 | 1 | 2 | Change From Baseline in the Sheehan Suicidality... |
| (Vss) | 3 | 3 | 0 | 3 | Volume of distribution (Vss) of SHR-1707 | Volu... |
| (SWM) | 3 | 3 | 1 | 2 | Change From Baseline in CANTAB Spatial Working ... |
| (BPRS) | 3 | 3 | 1 | 2 | Brief Psychiatric Rating Scale (BPRS) Total Sco... |
| (SUV) | 3 | 1 | 3 | 0 | brain inflammation assessed by [18F]-DPA714, St... |
| (Lp-PLA2) | 3 | 3 | 0 | 3 | Percentage Inhibition in Plasma Lipoprotein-ass... |
| (HbA1c) | 3 | 3 | 0 | 3 | Change From Baseline in Glycosylated Haemoglobi... |

## 전체 통계

- 전체 매칭되지 않은 약어 종류: 394개
- 전체 매칭되지 않은 약어 검출 횟수: 683건
